PSA in the New Millennium

A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database

Stephen J. Freedland, James M. Hotaling, Nicholas J. Fitzsimons, Joseph C. Presti, Christopher J. Kane, Martha Kennedy Terris, William J. Aronson, Christopher L. Amling

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objectives: As a result of prostate-specific antigen (PSA) screening, most men today with prostate cancer present with localized disease and serum PSA values < 10 ng/ml. Within this context, it is debated whether PSA remains an important prognostic variable in more recently treated patients. We examined the prognostic significance of preoperative PSA to predict pathologic stage and biochemical progression among men undergoing radical prostatectomy in the new millennium (2000-2006). Methods: We performed a review of 925 men with prostate cancer treated by radical prostatectomy since 2000 within the Shared Equal Access Regional Cancer Hospital (SEARCH) database. We examined the association between preoperative PSA and risk of adverse pathologic features and biochemical progression using logistic regression and Cox proportional hazards analysis. Results: After adjusting for multiple clinical preoperative characteristics, higher preoperative PSA values were associated with increased odds of extracapsular extension (p < 0.001), positive surgical margins (p < 0.001), and seminal vesicle invasion (p < 0.001) and increased risk of biochemical progression (p = 0.009). When the analyses were limited to the 690 men with a preoperative PSA < 10 ng/ml and after adjusting for multiple clinical characteristics, higher preoperative PSA values remained associated with increased risk of biochemical progression (hazard ratio [HR] 1.16, 95% confidence interval [CI] 1.06-1.28, p = 0.002). Even among the 448 men with a PSA < 10 ng/ml and clinical stage T1c disease, preoperative PSA was associated with increased risk of biochemical progression (HR 1.14, 95%CI 1.00-1.31, p = 0.047). Conclusions: PSA remains an important prognostic marker among men diagnosed with prostate cancer in the new millennium treated with radical prostatectomy and remains an important predictor of outcome even among men with preoperative PSA level < 10 ng/ml.

Original languageEnglish (US)
Pages (from-to)758-766
Number of pages9
JournalEuropean Urology
Volume53
Issue number4
DOIs
StatePublished - Apr 1 2008

Fingerprint

Cancer Care Facilities
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms
Databases
Confidence Intervals
Seminal Vesicles

Keywords

  • Biochemical recurrence
  • PSA
  • Prostate cancer
  • Radical prostatectomy

ASJC Scopus subject areas

  • Urology

Cite this

PSA in the New Millennium : A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database. / Freedland, Stephen J.; Hotaling, James M.; Fitzsimons, Nicholas J.; Presti, Joseph C.; Kane, Christopher J.; Terris, Martha Kennedy; Aronson, William J.; Amling, Christopher L.

In: European Urology, Vol. 53, No. 4, 01.04.2008, p. 758-766.

Research output: Contribution to journalArticle

Freedland, Stephen J. ; Hotaling, James M. ; Fitzsimons, Nicholas J. ; Presti, Joseph C. ; Kane, Christopher J. ; Terris, Martha Kennedy ; Aronson, William J. ; Amling, Christopher L. / PSA in the New Millennium : A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database. In: European Urology. 2008 ; Vol. 53, No. 4. pp. 758-766.
@article{ba1c2227b1ee45a1b22201b1cd1352b8,
title = "PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database",
abstract = "Objectives: As a result of prostate-specific antigen (PSA) screening, most men today with prostate cancer present with localized disease and serum PSA values < 10 ng/ml. Within this context, it is debated whether PSA remains an important prognostic variable in more recently treated patients. We examined the prognostic significance of preoperative PSA to predict pathologic stage and biochemical progression among men undergoing radical prostatectomy in the new millennium (2000-2006). Methods: We performed a review of 925 men with prostate cancer treated by radical prostatectomy since 2000 within the Shared Equal Access Regional Cancer Hospital (SEARCH) database. We examined the association between preoperative PSA and risk of adverse pathologic features and biochemical progression using logistic regression and Cox proportional hazards analysis. Results: After adjusting for multiple clinical preoperative characteristics, higher preoperative PSA values were associated with increased odds of extracapsular extension (p < 0.001), positive surgical margins (p < 0.001), and seminal vesicle invasion (p < 0.001) and increased risk of biochemical progression (p = 0.009). When the analyses were limited to the 690 men with a preoperative PSA < 10 ng/ml and after adjusting for multiple clinical characteristics, higher preoperative PSA values remained associated with increased risk of biochemical progression (hazard ratio [HR] 1.16, 95{\%} confidence interval [CI] 1.06-1.28, p = 0.002). Even among the 448 men with a PSA < 10 ng/ml and clinical stage T1c disease, preoperative PSA was associated with increased risk of biochemical progression (HR 1.14, 95{\%}CI 1.00-1.31, p = 0.047). Conclusions: PSA remains an important prognostic marker among men diagnosed with prostate cancer in the new millennium treated with radical prostatectomy and remains an important predictor of outcome even among men with preoperative PSA level < 10 ng/ml.",
keywords = "Biochemical recurrence, PSA, Prostate cancer, Radical prostatectomy",
author = "Freedland, {Stephen J.} and Hotaling, {James M.} and Fitzsimons, {Nicholas J.} and Presti, {Joseph C.} and Kane, {Christopher J.} and Terris, {Martha Kennedy} and Aronson, {William J.} and Amling, {Christopher L.}",
year = "2008",
month = "4",
day = "1",
doi = "10.1016/j.eururo.2007.08.047",
language = "English (US)",
volume = "53",
pages = "758--766",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - PSA in the New Millennium

T2 - A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes - Results from the SEARCH Database

AU - Freedland, Stephen J.

AU - Hotaling, James M.

AU - Fitzsimons, Nicholas J.

AU - Presti, Joseph C.

AU - Kane, Christopher J.

AU - Terris, Martha Kennedy

AU - Aronson, William J.

AU - Amling, Christopher L.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Objectives: As a result of prostate-specific antigen (PSA) screening, most men today with prostate cancer present with localized disease and serum PSA values < 10 ng/ml. Within this context, it is debated whether PSA remains an important prognostic variable in more recently treated patients. We examined the prognostic significance of preoperative PSA to predict pathologic stage and biochemical progression among men undergoing radical prostatectomy in the new millennium (2000-2006). Methods: We performed a review of 925 men with prostate cancer treated by radical prostatectomy since 2000 within the Shared Equal Access Regional Cancer Hospital (SEARCH) database. We examined the association between preoperative PSA and risk of adverse pathologic features and biochemical progression using logistic regression and Cox proportional hazards analysis. Results: After adjusting for multiple clinical preoperative characteristics, higher preoperative PSA values were associated with increased odds of extracapsular extension (p < 0.001), positive surgical margins (p < 0.001), and seminal vesicle invasion (p < 0.001) and increased risk of biochemical progression (p = 0.009). When the analyses were limited to the 690 men with a preoperative PSA < 10 ng/ml and after adjusting for multiple clinical characteristics, higher preoperative PSA values remained associated with increased risk of biochemical progression (hazard ratio [HR] 1.16, 95% confidence interval [CI] 1.06-1.28, p = 0.002). Even among the 448 men with a PSA < 10 ng/ml and clinical stage T1c disease, preoperative PSA was associated with increased risk of biochemical progression (HR 1.14, 95%CI 1.00-1.31, p = 0.047). Conclusions: PSA remains an important prognostic marker among men diagnosed with prostate cancer in the new millennium treated with radical prostatectomy and remains an important predictor of outcome even among men with preoperative PSA level < 10 ng/ml.

AB - Objectives: As a result of prostate-specific antigen (PSA) screening, most men today with prostate cancer present with localized disease and serum PSA values < 10 ng/ml. Within this context, it is debated whether PSA remains an important prognostic variable in more recently treated patients. We examined the prognostic significance of preoperative PSA to predict pathologic stage and biochemical progression among men undergoing radical prostatectomy in the new millennium (2000-2006). Methods: We performed a review of 925 men with prostate cancer treated by radical prostatectomy since 2000 within the Shared Equal Access Regional Cancer Hospital (SEARCH) database. We examined the association between preoperative PSA and risk of adverse pathologic features and biochemical progression using logistic regression and Cox proportional hazards analysis. Results: After adjusting for multiple clinical preoperative characteristics, higher preoperative PSA values were associated with increased odds of extracapsular extension (p < 0.001), positive surgical margins (p < 0.001), and seminal vesicle invasion (p < 0.001) and increased risk of biochemical progression (p = 0.009). When the analyses were limited to the 690 men with a preoperative PSA < 10 ng/ml and after adjusting for multiple clinical characteristics, higher preoperative PSA values remained associated with increased risk of biochemical progression (hazard ratio [HR] 1.16, 95% confidence interval [CI] 1.06-1.28, p = 0.002). Even among the 448 men with a PSA < 10 ng/ml and clinical stage T1c disease, preoperative PSA was associated with increased risk of biochemical progression (HR 1.14, 95%CI 1.00-1.31, p = 0.047). Conclusions: PSA remains an important prognostic marker among men diagnosed with prostate cancer in the new millennium treated with radical prostatectomy and remains an important predictor of outcome even among men with preoperative PSA level < 10 ng/ml.

KW - Biochemical recurrence

KW - PSA

KW - Prostate cancer

KW - Radical prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=39449121966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39449121966&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2007.08.047

DO - 10.1016/j.eururo.2007.08.047

M3 - Article

VL - 53

SP - 758

EP - 766

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 4

ER -